Followers | 3 |
Posts | 251 |
Boards Moderated | 0 |
Alias Born | 04/23/2013 |
Tuesday, April 24, 2018 1:24:22 PM
Below are comments about the CEO’s previous stock play. It was regarding Cobroxin, the former name for Nyloxin. Notice the similarities? Can a leopard change its spots?
Thinking
____________________________________________________________________
Rik Lied & Investors Cried
Pumpers and investors have been burned by Rik of NPHC and his false guidance of $16 - $20 million in Cobroxin sales from NPHC to HCHO. The following chain reaction has occurred:
1 - Rik has been exposed as a phony or incompetent CEO. Either he flat out lied about Cobroxin sales or he is an idiot who shot from the hips with some absurd sales predictions. His forecast has missed by so much that any scintilla of credibility is beyond reason. I say he both lied and is incompetent.
2 - Frank is a boob. No getting around it. He failed to get Cobroxin launched on time as promised and he failed to get the Ad campaign going on time. When he finally got the Ad campaign going, investors were playing "Where's Waldo?" trying to find Ads
3 - Rik has tried to cannibalize Cobroxin with Nyloxin - albeit a stronger product, but the same as Cobroxin in an extra strength guise - selling Nyloxin with another distributor. This is a clear rebuke of Frank.
4 - Rik has gone to the well again with another private placement. He said he would not have to do this because Cobroxin sales would keep NPHC afloat. This is a tacit acknowledgement that Frank has failed.
5 - Total silence and no specific upside guidance from XCHO.
Unless Frank pulls a Rabbit out of his hat with some specific positive news about a drastic jump in Cobroxin sales - stressing reorders - IMO XCHO is toast.
The desperate pumpers: Geo, Raphael and Brown are besides themselves with all kinds of BS pumps
Source: https://www.investorvillage.com/smbd.asp?mb=16383&mn=143&pt=msg&mid=9762569
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM